Goldenwell Biotech Inc
Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. It is developing JI MAI, a bovine cardiac vascular active peptide; Double Proline AG, a 3D active collagen peptide drinkable cosmetic; Cartilage Peptide, a Type II collagen peptide; and Sugar Master, a dietary supplement. The company was incorporated in 2019 and is based in Hudson, Ohio.
Market Cap & Net Worth: Goldenwell Biotech Inc (GWLL)
Goldenwell Biotech Inc (PINK:GWLL) has a market capitalization of $19.80 Million ($19.80 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #29938 globally and #9888 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Goldenwell Biotech Inc's stock price $0.20 by its total outstanding shares 99000000 (99.00 Million).
Goldenwell Biotech Inc Market Cap History: 2022 to 2025
Goldenwell Biotech Inc's market capitalization history from 2022 to 2025. Data shows change from $29.20 Million to $19.80 Million (-14.33% CAGR).
Goldenwell Biotech Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Goldenwell Biotech Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
142446.04x
Goldenwell Biotech Inc's market cap is 142446.04 times its annual revenue
0.14x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $29.20 Million | $47.80K | -$985.10K | 610.98x | N/A |
| 2023 | $5.80 Million | $2.34K | -$116.89K | 2479.23x | N/A |
| 2024 | $19.80 Million | $139.00 | -$131.50K | 142446.04x | N/A |
Competitor Companies of GWLL by Market Capitalization
Companies near Goldenwell Biotech Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Goldenwell Biotech Inc by market ranking:
- Nestle SA (PINK:NSRGF): Ranked #54 globally with a market cap of $258.19 Billion USD.
- Nestlé S.A. (SW:NESN): Ranked #69 globally with a market cap of $218.85 Billion USD ( CHF200.39 Billion CHF).
- Danone S.A (OTCQX:GPDNF): Ranked #435 globally with a market cap of $49.73 Billion USD.
- Danone SA (PA:BN): Ranked #465 globally with a market cap of $45.94 Billion USD ( €44.75 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #54 | Nestle SA | PINK:NSRGF | $258.19 Billion | $100.43 |
| #69 | Nestlé S.A. | SW:NESN | $218.85 Billion | CHF77.97 |
| #435 | Danone S.A | OTCQX:GPDNF | $49.73 Billion | $78.67 |
| #465 | Danone SA | PA:BN | $45.94 Billion | €70.78 |
Goldenwell Biotech Inc Historical Marketcap From 2022 to 2025
Between 2022 and today, Goldenwell Biotech Inc's market cap moved from $29.20 Million to $ 19.80 Million, with a yearly change of -14.33%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $19.80 Million | 0.00% |
| 2024 | $19.80 Million | +241.30% |
| 2023 | $5.80 Million | -80.14% |
| 2022 | $29.20 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Goldenwell Biotech Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $19.80 Million USD |
| MoneyControl | $19.80 Million USD |
| MarketWatch | $19.80 Million USD |
| marketcap.company | $19.80 Million USD |
| Reuters | $19.80 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.